Sign in
Active, not recruitingNo phase

Left Ventricular Impella Device Real-World Evaluation in Pediatric Patients

Key facts

Who runs it
Abiomed Inc.
Where
Atlanta, Aurora, Boston, Charleston, Chicago, Cincinnati, Dallas, Hollywood, Houston, Kansas City, Loma Linda, Los Angeles, Louisville, Memphis, Milwaukee, Nashville, New Hyde Park, New York, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Salt Lake City, and Seattle, United StatesSee the 24 sites
Trial code
Status
Active, not recruiting
People taking part
60 people, planned
Started
3 Dec 2024
Expected to end
Dec 2027
Type of study
Observational
Treatments tested
  • Impella CP with SmartAssist
  • Impella 5.5 with SmartAssist
Record updated
17 November 2026

Who can take part

Age
Up to 21 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Patient received a left/systemic ventricular Impella device: Impella CPSA and/or Impella 5.5
  • Age < 22 years

Who cannot take part

  • Age ≥ 22 years

Where in United States

  • Children's Healthcare of AtlantaAtlanta, United States
  • Children's Hospital ColoradoAurora, United States
  • Boston Children's HospitalBoston, United States
  • MUSC Children's HealthCharleston, United States
  • Lurie Children's Hospital of ChicagoChicago, United States
  • Cincinnati Children's Hospital Medical CenterCincinnati, United States
  • Children's Medical Center DallasDallas, United States
  • Joe DiMaggio Children's HospitalHollywood, United States
  • Texas Children's HospitalHouston, United States
  • Children's Mercy HospitalKansas City, United States
  • Loma Linda University Children's HospitalLoma Linda, United States
  • Children's Hospital Los AngelesLos Angeles, United States
  • Norton Children's HospitalLouisville, United States
  • Le Bonheur Children's HospitalMemphis, United States
  • Children's Hospital of WisconsinMilwaukee, United States
  • Monroe Carell Jr. Children's Hospital at VanderbiltNashville, United States
  • Cohen Children's Medical CenterNew Hyde Park, United States
  • New York -Presbyterian Morgan Stanley Children's HospitalNew York, United States
  • Lucile Packard Children's Hospital - StanfordPalo Alto, United States
  • Children's Hospital of PhiladelphiaPhiladelphia, United States
  • Phoenix Children s HospitalPhoenix, United States
  • UPMC Children's Hospital of PittsburghPittsburgh, United States
  • Primary Children's HospitalSalt Lake City, United States
  • Seattle Children's HospitalSeattle, United States

About the trial

What the trial wants to find out

This post-approval study will evaluate the real-world safety and effectiveness of the Impella CP with SmartAssist and Impella 5.5 with SmartAssist heart pumps in pediatric patients with cardiogenic shock or severe heart failure requiring temporary mechanical circulatory support.

Read full original descriptionShow less

The study will collect data from children and young adults younger than 22 years of age who receive an Impella device as part of their routine clinical care at hospitals participating in the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) registry.

The primary objective is to assess survival at the time the Impella device is removed. Information collected during the patient's hospitalization, including clinical outcomes and adverse events, will be used to further evaluate the performance of these commercially approved devices in the pediatric population.

The group in the trial

  • Pediatric Patients Receiving Impella Support

    Pediatric patients younger than 22 years of age who receive a commercially approved left ventricular Impella device (Impella CP with SmartAssist and/or Impella 5.5 with SmartAssist) as part of routine clinical care and are enrolled through the ACTION (Advanced Cardiac Therapies Improving Outcomes Network) registry.

    Treatment: Impella CP with SmartAssist and Impella 5.5 with SmartAssist

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 November 2026